Stay updated on ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Sign up to get notified when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.

Latest updates to the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page
- Check2 days agoChange DetectedThe page footer now shows Revision: v3.6.6 instead of v3.6.5. No study content, eligibility details, or results appear to be affected.SummaryDifference0.0%

- Check9 days agoChange DetectedA funding line indicates the study received a US NIH grant/contract in 2016, updating the funding disclosure.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5. This indicates a backend/UI update to the ClinicalTrials.gov page without changing study data or visible content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe revision label on the page updates from v3.6.3 to v3.6.4. This indicates a small page update.SummaryDifference0.0%

- Check66 days agoChange DetectedThe revision label on the page changed from v3.6.0 to v3.6.3, indicating a minor internal update to the page. This does not alter study content or user-facing information.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page now displays recruitment status indicating no further participant enrollment and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), while standardizing the Intervention/Treatment heading and updating the revision to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Enter your email address, and we'll notify you when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.